There are currently 627 clinical trials in Austin, Texas looking for participants to engage in research studies. Trials are conducted at various facilities, including GSK Investigational Site, Dell Childrens Medical Center of Central Texas, Pfizer Investigational Site and University of Texas at Austin. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Accelerated Intermittent Theta Burst in Treatment-Naive Adolescents
NCT06523439
Recruiting
This is a single-site open-label clinical trial of the Stanford Accelerated Intermittent Neuromodulation Therapy (SAINT®) protocol. The goal of this clinical trial is to learn if a new form of transcranial magnetic stimulation (TMS)-known generally as accelerated intermittent theta burst stimulation (aiTBS) and specifically as SAINT®-is effective as a first-line therapy in treating adolescents aged 14-19 years-old in their first episode of depression who have not undergone a full course of depre... Read More
Gender:
ALL
Ages:
Between 14 years and 19 years
Trial Updated:
12/06/2024
Locations: Dell Medical School at University of Texas at Austin, Austin, Texas
Conditions: Major Depressive Disorder, Depression in Adolescence, Depression, Major Depressive Episode
Register for Updates
Post-Market Study to Assess iTind Safety in Comparison to UroLift
NCT04757116
Recruiting
The study objective is to evaluate the safety of the iTind device comparied to UroLift.
Gender:
MALE
Ages:
50 years and above
Trial Updated:
12/05/2024
Locations: Midtown Urology Associates, Austin, Texas
Conditions: Benign Prostatic Hyperplasia (BPH)
Register for Updates
Urinary Catheter Self-Discontinuation After Urogynecology Surgery
NCT05860634
Recruiting
The goal of this randomized clinical trial is to determine if removal of transurethral urinary catheters by patients at home is as safe as catheter removal in the office following urogynecologic surgery. Participants will be randomized to either standard catheter removal in the office or catheter self-removal at home.
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
12/05/2024
Locations: University of Texas of Austin - Dell Seton Medical Center, Austin, Texas +1 locations
Conditions: Urinary Retention, Pelvic Organ Prolapse, Stress Urinary Incontinence, Catheter Related Complication
Register for Updates
Closed-Loop Brain Stimulation as a Potential Intervention for Cognitive Decline
NCT05907343
Recruiting
The goal of this clinical study is to investigate the effectiveness of non-invasive stimulation to enhance cognitive control abilities in cognitively healthy adults and older adults diagnosed with mild cognitive disorder (MCI). The main questions it aims to answer are: * whether it is possible to restore various cognitive functions in older adults diagnosed with MCI by delivering theta burst stimulation (TBS), a form of transcranial magnetic stimulation, and * whether closed-loop TBS is able to... Read More
Gender:
ALL
Ages:
Between 18 years and 90 years
Trial Updated:
12/04/2024
Locations: Health Discovery Building, Austin, Texas
Conditions: Mild Cognitive Impairment
Register for Updates
Real-time Personalized Brain State-dependent TMS After Stroke
NCT06533176
Recruiting
Transcranial magnetic stimulation (TMS) interventions could feasibly strengthen residual corticospinal tract (CST) connections and enhance recovery of paretic hand function after stroke. This project will test whether personalized brain state-dependent TMS can activate the residual corticospinal tract better than standard TMS, and evaluate the relationship between this activation and hand motor impairment.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
12/04/2024
Locations: University of Texas at Austin, Austin, Texas
Conditions: Stroke
Register for Updates
Efficacy of the ASPEN Intervention Program in Low-Resource Communities
NCT04505488
Recruiting
The ASD Screening and Parent ENgagement (ASPEN) program is a culturally adapted, parent-mediated intervention program. The ASPEN program is tailored to address social communication and behavioral difficulties that young children with developmental delays may experience in early childhood. The ASPEN Program includes 12 sessions where parents are provided with psychoeducation about self-care, child development, and evidence-based strategies. Coaching is also provided to train parents on using evid... Read More
Gender:
ALL
Ages:
Between 18 months and 6 years
Trial Updated:
12/03/2024
Locations: University of Texas at Austin, Austin, Texas
Conditions: Autism Spectrum Disorder
Register for Updates
4D-150 in Patients With Diabetic Macular Edema
NCT05930561
Recruiting
Phase 2 randomized, active-controlled, double-masked, dose-ranging trial in adults with Diabetic Macular Edema (DME).
Gender:
ALL
Ages:
18 years and above
Trial Updated:
12/03/2024
Locations: Austin Clinical Research, Austin, Texas
Conditions: Diabetic Macular Edema, Diabetic Retinopathy
Register for Updates
A Randomized Controlled Trial of Impact of Wearable, Wireless Breast Pumps on Frequency and Efficacy of Milk Expression in Mothers of Premature Infants
NCT06723067
Recruiting
A randomized controlled trial of impact of wearable, wireless breast pumps on how often and how much milk mothers of premature infants can pump.
Gender:
FEMALE
Ages:
All
Trial Updated:
12/03/2024
Locations: Ascension Seton Medical Center, Austin, Texas
Conditions: Premature Birth
Register for Updates
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
NCT06451497
Recruiting
This is a phase 1 dose escalation trial of ZM008, an anti-LLT1 antibody as a single agent followed by combination with Pembrolizumab in patients with advanced solid tumors who have exhausted all standard therapy available or are intolerant of the same.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/29/2024
Locations: NEXT Oncology, Austin, Texas
Conditions: Non Small Cell Lung Cancer, Esophageal Cancer, Head and Neck Squamous Cell Carcinoma, Pancreas Adenocarcinoma, Biliary Tract Cancer, Prostate Cancer, Urothelial Carcinoma, Colorectal Cancer, Triple Negative Breast Cancer, High Grade Ovarian Serous Adenocarcinoma, Diffuse Large B Cell Lymphoma
Register for Updates
A Study of ADRX-0405 in Subjects with Select Advanced Solid Tumors
NCT06710379
Recruiting
The primary purpose of this study is to assess the safety, tolerability, and pharmacokinetics, and to identify the optimal dose of ADRX-0405 in patients with select advanced solid tumors.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/26/2024
Locations: NEXT Austin, Austin, Texas
Conditions: Solid Tumors
Register for Updates
A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis
NCT06431373
Recruiting
The purpose of this study is to determine the safety and efficacy of brepocitinib in participants with active, non-anterior (intermediate, posterior, or pan) non-infectious uveitis (NIU).
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
11/25/2024
Locations: Clinical Trial Site, Austin, Texas
Conditions: Uveitis, Posterior, Uveitis, Intermediate, Uveitis
Register for Updates
A Study of ZN-c3 in Women With Recurrent or Persistent Uterine Serous Carcinoma
NCT04814108
Recruiting
This is a Phase 2 study to evaluate the clinical activity and safety of ZN-c3 (azenosertib) in adult women with recurrent or persistent uterine serous carcinoma (USC).
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
11/19/2024
Locations: Texas Oncology Austin, Austin, Texas
Conditions: Uterine Serous Carcinoma
Register for Updates